Amrize Ltd (AMRZ Quick QuoteAMRZ - Free Report) reported $3.77 billion in revenue for the quarter ended September 2026, representing a year-over-year increase of 2.6%. EPS of $1.02 for the same period compares to $1.06 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $3.85 billion, representing a surprise of -1.99%. The company delivered an EPS surprise of +4.08%, with the consensus EPS estimate being $0.98.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Amrize Ltd performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Building Envelope: $929 million versus the three-analyst average estimate of $930.97 million. The reported number represents a year-over-year change of +3.1%.
• Revenues- Building Materials: $2.84 billion versus the three-analyst average estimate of $2.95 billion. The reported number represents a year-over-year change of +2.5%.
• Adjusted EBITDA- Building Materials: $938 million versus the three-analyst average estimate of $943.93 million.
• Adjusted EBITDA- Building Envelope: $182 million versus the three-analyst average estimate of $191.19 million.
• Adjusted EBITDA- Unallocated corporate costs: $-44 million versus $-49.5 million estimated by two analysts on average.

View all Key Company Metrics for Amrize Ltd here>>>

Shares of Amrize Ltd have returned +6.7% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #5 (Strong Sell), indicating that it could underperform the broader market in the near term.